12202 Federal Register / Vol. 71, No.
46 / Thursday, March 9, 2006 / Notices
estimation and reconstruction efforts being
performed for purposes of the compensation
program, and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2007.
Purpose: This board is charged with (a)
providing advice to the Secretary, HHS, on
the development of guidelines under
Executive Order 13179; (b) providing advice
to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction
efforts performed for this Program; and (c)
upon request by the Secretary, HHS, advise
the Secretary on whether there is a class of
employees at any Department of Energy
facility who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such radiation
doses may have endangered the health of
members of this class.
Matters to be Discussed: The agenda for the
conference call includes board comments on
SEC rule rewrite; reports of working groups
on Y–12 Site Profile, Rocky Flats Site Profile,
individual dose reconstruction reviews—Sets
2 and 3, Procedures Review (Task 3), and
Sanford Cohen & Associates (SC&A) progress
on the SEC task; NIOSH update on
Bethlehem Steel Site Profile; board
correspondence; agenda for the April 25–27,
2006 meeting; and future board/work group
schedules and meetings.
The agenda is subject to change as
priorities dictate.
Due to administrative issues that had to be
resolved the Federal Register notice is being
published on short notice.
Contact Person for More Information: Dr.
Lewis V. Wade, Executive Secretary, NIOSH,
CDC, 4676 Columbia Parkway, Cincinnati,
Ohio 45226, telephone 513/533–6825, fax
513/533–6826.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: March 3, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
hsrobinson on PROD1PC70 with NOTICES
[FR Doc. E6–3347 Filed 3–8–06; 8:45 am]
BILLING CODE 4163–18–P
VerDate Aug<31>2005 13:58 Mar 08, 2006 Jkt 208001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Clinical Center; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the NIH
Advisory Board for Clinical Research.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: NIH Advisory Board
for Clinical Research.
Date: March 24, 2006.
Time: 10 a.m. to 2 p.m.
Agenda: To review proposed 2007 Clinical
Center budget.
Place: National Institutes of Health,
Building 10, 10 Center Drive, 4–2551, CRC
Medical Board Room, Bethesda, MD 20892.
Contact Person: Maureen E. Gormley,
Executive Secretary, Mark O. Hatfield
Clinical Research Center, National Institutes
of Health, Building 10, Room 6–2551,
Bethesda, MD 20892, 301/496–2897.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Dated: February 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–2209 Filed 3–8–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\09MRN1.SGM
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
D—Clinical Studies.
Date: April 9–10, 2006.
Time: 6 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Peter J. Wirth, PhD,
Scientific Review Administrator, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, 6116 Executive Boulevard, Room
8131, Bethesda, MD 20892–8328. 301–496–
7565. pw2q@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–2229 Filed 3–8–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Initial Review Group,
Research Centers In Minority Institutions
Review Committee.
Date: March 16, 2006.
Time: 8 a.m. to 5 p.m.
09MRN1